Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Legha, S. S.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

LETTER

Are Protected Environments Necessary for Recipients of Bone Marrow Transplants?

right arrow Sewa S. Legha, MD

1 July 1994 | Volume 121 Issue 1 | Page 76


TO THE EDITOR:

Rowe and associates [1] recently provided guidelines for managing patients who have received autologous or allogeneic bone marrow transplantation for cancer. Although they covered most of the common problems, they did not comment on the preventive aspects of the common infectious complications. Protected environments with laminar air-flow facilities or air filtration devices have been used for several years. Can myeloablative therapy be delivered in a regular ward setting without requiring a special isolation unit or provision for protected environment? Could the authors provide the pros and cons of the need for "sterile" environment and of the value of facilities for conducting high-dose chemotherapy, which is increasingly used by medical oncologists in both community hospitals and major cancer centers? The provision of such environments is costly, so it is important to know if such facilities are indispensable.


Author and Article Information
space
up arrowTop
dotAuthor & Article Info
down arrowREFERENCE

The University of Texas; M. D. Anderson Cancer Center; Houston, TX 77030


REFERENCE
space
up arrowTop
up arrowAuthor & Article Info
dotREFERENCE

1. Rowe JM, Ciobanu N, Ascensao J, Stadtmauer EA, Weiner RS, Schenkein DP, et al. Recommended guidelines for the management of autologous and allogeneic bone marrow transplantation: a report from the Eastern Cooperation Oncology Group (ECOG). Ann Intern Med. 1994; 120:143-58.

About Letters
space

The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

•Include no more than 300 words of text, three authors, and five references

•Type with double-spacing

•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

Annals welcomes electronically submitted letters.





box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Legha, S. S.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space


 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online